ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $649 | +18.6% | 69 | +40.8% | 0.00% | – |
| Q3 2023 | $547 | -95.5% | 49 | -91.3% | 0.00% | -100.0% |
| Q2 2023 | $12,048 | +185.0% | 563 | +436.2% | 0.00% | +300.0% |
| Q1 2023 | $4,227 | -18.9% | 105 | -6.2% | 0.00% | -50.0% |
| Q4 2022 | $5,210 | -25.6% | 112 | -21.7% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | +40.0% | 143 | +37.5% | 0.00% | +50.0% |
| Q2 2022 | $5,000 | -28.6% | 104 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | -36.4% | 104 | -28.3% | 0.00% | -50.0% |
| Q4 2021 | $11,000 | +37.5% | 145 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $8,000 | +166.7% | 145 | +137.7% | 0.00% | +200.0% |
| Q2 2021 | $3,000 | 0.0% | 61 | +7.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | +200.0% | 57 | +147.8% | 0.00% | 0.0% |
| Q1 2020 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -91.7% | 23 | -67.1% | 0.00% | -100.0% |
| Q1 2019 | $12,000 | +140.0% | 70 | -15.7% | 0.00% | +50.0% |
| Q4 2018 | $5,000 | -28.6% | 83 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $7,000 | -22.2% | 83 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $9,000 | +50.0% | 83 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $6,000 | +50.0% | 83 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +33.3% | 83 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | -40.0% | 83 | -47.8% | 0.00% | -33.3% |
| Q2 2017 | $5,000 | 0.0% | 159 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $5,000 | 0.0% | 170 | -1.7% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | +25.0% | 173 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $4,000 | – | 173 | +981.2% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 16 | -89.6% | 0.00% | -100.0% |
| Q1 2016 | $4,000 | +300.0% | 154 | +294.9% | 0.00% | +100.0% |
| Q4 2015 | $1,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |